It was also shown that streptonigrin at 0.05 μM markedly decreased clonogenic survival of pancreatic cancer cells expressing NQO1 at elevated levels but not of colorectal cancer cells with lower levels of this enzyme [40]. Here, NQO1 is linked to pancreatic neoplasm.